In a new discovery, chronic pain has been shown to be physiologically different from acute pain and now scientists have the ...

I Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) (Nasdaq: BDRX), a clinical stage biopharmaceutical company developing a pipeline of ...

namely GPCR kinases and second message kinases (such as protein kinase A and protein kinase C) (Lefkowitz, 1998). A large number of GPCR phosphorylation sites have been reported, mostly using mass ...

Insilico plans late-stage trials for rentosertib following positive mid-stage safety and efficacy data for idiopathic ...

Identifying proteomic signatures of insulin resistance in fasting muscle offers insights for personalized type 2 diabetes ...